Tricyclic compound and medical use thereof
    8.
    发明授权
    Tricyclic compound and medical use thereof 有权
    三环化合物及其医疗用途

    公开(公告)号:US08273761B2

    公开(公告)日:2012-09-25

    申请号:US12448094

    申请日:2007-12-07

    IPC分类号: C07D491/048 A61K31/4355

    CPC分类号: C07D491/04 C07D491/14

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s), R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s), R3 is a hydrogen atom, a halogen atom, a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or mercapto optionally having a substituent, Xa to Xe are each a carbon atom or a nitrogen atom, m is 0 to 2, and ring A to ring C are each a ring optionally having substituent(s), or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物,其中R 1是任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基,R2是 氢原子或任选具有取代基的烃基,R 3是氢原子,卤素原子,任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的巯基, 取代基,Xa〜Xe各自为碳原子或氮原子,m为0〜2,环A〜环C各自为任选具有取代基的环,或其盐,可用作试剂 用于预防或治疗与褪黑素的作用相关的疾病等。

    Bicyclic compound and pharmaceutical use thereof
    9.
    发明授权
    Bicyclic compound and pharmaceutical use thereof 有权
    双环化合物及其药物用途

    公开(公告)号:US08110585B2

    公开(公告)日:2012-02-07

    申请号:US12451090

    申请日:2008-04-25

    摘要: The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s); R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); Xa and Xb are each C, N, O or S; Xc and Xd are each C or N; m is 0-2; n is 1-3; ring A is a 5-membered ring optionally having substituent(s); ring B is a 6-membered ring optionally having substituent(s); and ring C is a 3- to 5-membered ring optionally having substituent(s), provided that when Xa, Xc and Xd are each C, then Xb is N or S, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

    摘要翻译: 本发明提供由下式表示的化合物:其中R 1为任选具有取代基的烃基,任选具有取代基的氨基,任选具有取代基的羟基或任选具有取代基的杂环基; R2是氢原子或任选具有取代基的烃基; Xa和Xb各自为C,N,O或S; Xc和Xd分别为C或N; m为0-2; n为1-3; 环A是任选具有取代基的5元环; 环B是任选具有取代基的6元环; 并且环C是任选具有取代基的3至5元环,条件是当Xa,Xc和Xd各自为C时,则Xb为N或S,或其盐,其可用作 与褪黑素的作用有关的疾病的预防或治疗等。